The podocyte: a potential therapeutic target in diabetic nephropathy?
about
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Shiga toxin pathogenesis: kidney complications and renal failure.Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats.The glomerulus--a view from the outside--the podocyte.Mechanisms by which heme oxygenase rescue renal dysfunction in obesity.Morphine induces albuminuria by compromising podocyte integrityMessenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathyCharacterization and culture of fetal rhesus monkey renal cortical cells.Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions.High glucose induces autophagy in podocytes.Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy.Glomerular Filtration Barrier Assembly: An insightThe heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in Zucker diabetic fatty rats.Losartan chemistry and its effects via AT1 mechanisms in the kidneyRethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expressionSystemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats.
P2860
Q33394010-C9E88F45-6977-4FCD-B807-2BEFC5B9EAC0Q33397541-A25A57D5-48D2-4F3E-8CBA-40BDC644D241Q33832394-D72EFA60-7BB2-4223-83A9-5327AE21E003Q34020798-8D5F1872-B15C-462C-BD98-D85C9B2A38D7Q34431848-F696670E-B54E-44F8-80C7-B61018E55311Q34650153-E0C5D18E-CAD2-41DB-A8DF-8340497DA0DDQ35011234-AF41D4C2-586E-4185-A2E1-8E661F00B22BQ35219396-712644C2-E672-460B-B281-D7031D466B71Q35624799-F4F387B4-50BA-4165-A402-CBD2749676DDQ36773098-5B7E1AF9-84EE-4D45-B80E-CF70C7DAA33BQ37088054-00A9D8A4-AAE3-439A-BAC3-C3631AA20B24Q37207268-2A10C9D0-AE5F-4045-B4FC-4EC12904F50BQ37214152-8568A3D2-39C6-409E-BB9B-4ED6E184F9EEQ37534705-15842B4B-5C99-44DD-A27A-9641BE2B7CB8Q37595616-1B485AD9-D9D3-4C60-9747-0669AC225877Q38942962-60DCE8BD-8306-485D-9792-C014B93A72D3Q41998066-50000845-A55F-40B6-A657-56FEE4A5E64FQ43814835-4A28792E-B3B0-4372-8752-18DB0A48F4ECQ45977204-E51346FC-0EBF-4FFA-AC61-281EBC2D2772
P2860
The podocyte: a potential therapeutic target in diabetic nephropathy?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The podocyte: a potential therapeutic target in diabetic nephropathy?
@en
type
label
The podocyte: a potential therapeutic target in diabetic nephropathy?
@en
prefLabel
The podocyte: a potential therapeutic target in diabetic nephropathy?
@en
P1476
The podocyte: a potential therapeutic target in diabetic nephropathy?
@en
P2093
Sally M Marshall
P304
P356
10.2174/138161207781662957
P577
2007-01-01T00:00:00Z